|
|
Request Number: 5.5
The Office of Technology Management is in contact with a company who is looking to in- license-exclusive or non-exclusive monoclonal or polyclonal antibodies specific for the following targets:
- Apo-E2 - Protein implied in the evolution of Alzheimer's Disease
- Apo-E3 - Protein implied in the evolution of Alzheimer's Disease
- Apo-E4 - Protein implied in the evolution of Alzheimer's Disease
- Aph-1 - Protein implied in the evolution of Alzheimer's Disease
- Notch - Protein implied in the evolution of Alzheimer's Disease
- Presenilin-1 - Protein implied in the evolution of Alzheimer's Disease
- Presenilin-2 - Protein implied in the evolution of Alzheimer's Disease
- Park-8 - Protein implied in the evolution of Parkinson's Disease
- Pink-1 - Protein implied in the evolution of Parkinson's Disease
- Bace 1,Bace 2 - Protein implied in the evolution of Alzheimer's Disease
- Pen-2 - Protein implied in the evolution of Alzheimer's Disease
- Bag5 - Protein implied in the Parkinson's Disease
- sAPPbeta - Protein implied in the Alzheimer's Disease
Please contact the Office of Technology Management if you have any technology that may be relevant to this request. |